OQROGet OQRO Pro
Insider trade

PTC Therapeutics, Inc. (PTCT)CEO sold ~$97K

Matthew B. Klein, CEO at PTC Therapeutics, Inc., sold ~$97K of PTC Therapeutics, Inc. shares.

~$97K
Approx. value · 2,142 sh @ $45.34
286K
Holds after · shares reported
Traded
Jan 7, 2025
Filed
Jan 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 2, 2024Insider · 4 peopleInsiders: 17 sales (~$10.4M)
  2. Dec 3, 2024Insider · 1 personInsiders: 5 sales (~$549K)
  3. Dec 31, 2024InsiderCEO sold ~$374K of PTCT shares in the open market
  4. Jan 7, 2025 · this disclosureInsiderCEO sold ~$97K of PTCT shares in the open market

What came next

  1. Jan 7, 2025Insider · 5 peopleInsiders: 6 sales (~$298K)
  2. Jan 8, 2025Insider · 6 peopleInsiders: 7 sales (~$492K)
  3. Feb 19, 2025Insider · 7 peopleInsiders: 8 sales (~$540K)
  4. Feb 20, 2025Insider · 7 peopleInsiders: 8 sales (~$586K)
  5. Mar 4, 2025InsiderDirector sold ~$63K of PTCT shares in the open market
  6. Mar 10, 2025Insider · 1 personInsiders: 4 sales (~$3.6M)
  7. Mar 11, 2025InsiderOfficer sold ~$300K of PTCT shares in the open market
  8. Mar 12, 2025Insider · 1 personInsiders: 2 sales (~$827K)
  9. Mar 13, 2025InsiderDirector sold ~$270K of PTCT shares in the open market
  10. Mar 14, 2025InsiderOfficer sold ~$246K of PTCT shares in the open market
  11. Mar 17, 2025Insider · 1 personInsiders: 4 sales (~$384K)
  12. Apr 2, 2025InsiderOfficer sold ~$42K of PTCT shares in the open market
  13. Apr 22, 2025InsiderCEO sold ~$137K of PTCT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for PTC Therapeutics, Inc.

For PTC Therapeutics, Inc., OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PTCT page.

Other recent filings by Matthew B. Klein, CHIEF EXECUTIVE OFFICER

The full history of Matthew B. Klein, CHIEF EXECUTIVE OFFICER is on the profile page.

How this filing works

Other disclosures at PTC Therapeutics, Inc.

Everything OQRO holds on this company is on its PTCT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data